J Z Ilich1, J E Inglis2, O J Kelly3, D L McGee4. 1. Department of Nutrition, Food and Exercise Sciences, Florida State University, 120 Convocation Way, 418 Sandels Building, Tallahassee, FL, 32306-1493, USA. jilichernst@fsu.edu. 2. Department of Nutrition, Food and Exercise Sciences, Florida State University, 120 Convocation Way, 418 Sandels Building, Tallahassee, FL, 32306-1493, USA. 3. Abbott Nutrition, Scientific and Medical Affairs, Columbus, OH, 43219, USA. 4. Department of Statistics, Florida State University, Tallahassee, FL, 32306, USA.
Abstract
UNLABELLED: We determined the prevalence of osteosarcopenic obesity (loss of bone and muscle coexistent with increased adiposity) in overweight/obese postmenopausal women and compared their functionality to obese-only women. Results showed that osteosarcopenic obese women were outperformed by obese-only women in handgrip strength and walking/balance abilities indicating their higher risk for mobility impairments. INTRODUCTION: Osteosarcopenic obesity (OSO) is a recently defined triad of osteopenia/osteoporosis, sarcopenia, and adiposity. We identified women with OSO in overweight/obese postmenopausal women and evaluated their functionality comparing them with obese-only (OB) women. Additionally, women with osteopenic/osteoporotic obesity (OO), but no sarcopenia, and those with sarcopenic obesity (SO), but no osteopenia/osteoporosis, were identified and compared. We hypothesized that OSO women will have the lowest scores for each of the functionality measures. METHODS: Participants (n = 258; % body fat ≥35) were assessed using a Lunar iDXA instrument for bone and body composition. Sarcopenia was determined from negative residuals of linear regression modeled on appendicular lean mass, height, and body fat, using 20th percentile as a cutoff. Participants with T-scores of L1-L4 vertebrae and/or total femur <-1, but without sarcopenia, were identified as OO (n = 99) and those with normal T-scores, but with sarcopenia, as SO (n = 28). OSO (n = 32) included women with both osteopenia/osteoporosis and sarcopenia, while those with normal bone and no sarcopenia were classified as OB (n = 99). Functionality measures such as handgrip strength, normal/brisk walking speed, and right/left leg stance were evaluated and compared among groups. RESULTS: Women with OSO presented with the lowest handgrip scores, slowest normal and brisk walking speed, and shortest time for each leg stance, but these results were statistically significantly different only from the OB group. CONCLUSION: These findings indicate a poorer functionality in women presenting with OSO, particularly compared to OB women, increasing the risk for bone fractures and immobility from the combined decline in bone and muscle mass, and increased fat mass.
UNLABELLED: We determined the prevalence of osteosarcopenic obesity (loss of bone and muscle coexistent with increased adiposity) in overweight/obese postmenopausal women and compared their functionality to obese-onlywomen. Results showed that osteosarcopenic obesewomen were outperformed by obese-onlywomen in handgrip strength and walking/balance abilities indicating their higher risk for mobility impairments. INTRODUCTION:Osteosarcopenic obesity (OSO) is a recently defined triad of osteopenia/osteoporosis, sarcopenia, and adiposity. We identified women with OSO in overweight/obese postmenopausal women and evaluated their functionality comparing them with obese-only (OB) women. Additionally, women with osteopenic/osteoporotic obesity (OO), but no sarcopenia, and those with sarcopenic obesity (SO), but no osteopenia/osteoporosis, were identified and compared. We hypothesized that OSO women will have the lowest scores for each of the functionality measures. METHODS:Participants (n = 258; % body fat ≥35) were assessed using a Lunar iDXA instrument for bone and body composition. Sarcopenia was determined from negative residuals of linear regression modeled on appendicular lean mass, height, and body fat, using 20th percentile as a cutoff. Participants with T-scores of L1-L4 vertebrae and/or total femur <-1, but without sarcopenia, were identified as OO (n = 99) and those with normal T-scores, but with sarcopenia, as SO (n = 28). OSO (n = 32) included women with both osteopenia/osteoporosis and sarcopenia, while those with normal bone and no sarcopenia were classified as OB (n = 99). Functionality measures such as handgrip strength, normal/brisk walking speed, and right/left leg stance were evaluated and compared among groups. RESULTS:Women with OSO presented with the lowest handgrip scores, slowest normal and brisk walking speed, and shortest time for each leg stance, but these results were statistically significantly different only from the OB group. CONCLUSION: These findings indicate a poorer functionality in women presenting with OSO, particularly compared to OBwomen, increasing the risk for bone fractures and immobility from the combined decline in bone and muscle mass, and increased fat mass.
Entities:
Keywords:
Handgrip strength; One leg stance; Osteopenic/osteoporotic obesity; Osteosarcopenic obesity; Sarcopenic obesity; Walking speed
Authors: Elisabetta Savino; Emilio Martini; Fulvio Lauretani; Giulio Pioli; Anna Maria Zagatti; Carlo Frondini; Francesca Pellicciotti; Antonio Giordano; Alberto Ferrari; Anna Nardelli; Maria Luisa Davoli; Amedeo Zurlo; Maria Lia Lunardelli; Stefano Volpato Journal: Am J Med Date: 2013-09-18 Impact factor: 4.965
Authors: D S Domiciano; C P Figueiredo; J B Lopes; V F Caparbo; L Takayama; P R Menezes; E Bonfa; R M R Pereira Journal: Osteoporos Int Date: 2012-05-16 Impact factor: 4.507
Authors: Bjoern Buehring; Karen E Hansen; Brian L Lewis; Steven R Cummings; Nancy E Lane; Neil Binkley; Kristine E Ensrud; Peggy M Cawthon Journal: J Bone Miner Res Date: 2018-06-21 Impact factor: 6.741
Authors: Pratima Sharma; Neehar D Parikh; Jessica Yu; Pranab Barman; Brian A Derstine; Christopher J Sonnenday; Stewart C Wang; Grace L Su Journal: Liver Transpl Date: 2016-06-29 Impact factor: 5.799